Upload Avatar (500 x 500)
Mao Yubin
maoyubin@xmu.edu.cn
Chinese, English
Fujian
Xiamen University
Medical
  • 1988-1993 Bachelor of Medicine: Xi'an Medical University
  • 1995-1998 Master of Medicine: Xi'an Medical University
  • 2004-2007 Doctor of Science: Xiamen University
  • 1993-1998 - Xi'an Jiaotong University School of Medicine - Teaching Assistant
  • 1998-2002 - Xiamen City Hospital of Traditional Chinese Medicine - Attending Physician
  • 2002-2008 - Xiamen University School of Medicine - Assistant Professor
  • 2008-present - Xiamen University School of Medicine - Associate Professor
Pathology of Tumors
  • MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2, Fan C, Lin Y, Mao Y, Huang Z, Liu AY, Ma H, Yu D, Maitikabili A, Xiao H, Zhang C, Liu F, Luo Q, Ouyang G, 2016
  • Periostin promotes immunosuppressive premetastatic niche formation to facilitate breast tumour metastasis, Wang Z, Xiong S, Mao Y, Chen M, Ma X, Zhou X, Ma Z, Liu F, Huang Z, Luo Q, Ouyang G, 2016
  • Involvement of Wnt/β-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma, Wang W, Zhong W, Yuan J, Yan C, Hu S, Tong Y, Mao Y, Hu T, Zhang B, Song G, 2015
  • Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24, Liu AY, Cai Y, Mao Y, Lin Y, Zheng H, Wu T, Huang Y, Fang X, Lin S, Feng Q, Huang Z, Yang T, Luo Q, Ouyang G, 2014
  • The Role of Nuclear β-Catenin Accumulation in the Twist2-Induced Ovarian Cancer EMT, Mao Y, Xu J, Li Z, Zhang N, Yin H, Liu Z, 2013
  • Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth, Cheng L, Huang Z, Zhou W, Wu Q, Donnola S, Liu JK, Fang X, Sloan AE, Mao Y, Lathia JD, Min W, McLendon RE, Rich JN, Bao S, 2013
  • iTRAQ Based Quantitative Proteomics Approach Validated the Role of Calcyclin Binding Protein (CacyBP) in Promoting Colorectal Cancer Metastasis, Ghosh D, Li Z, Tan XF, Lim TK, Mao Y, Lin Q, 2013
  • Significance of heterogeneous Twist2 expression in human breast cancers, Mao Y, Zhang N, Xu J, Ding Z, Zong R, et al., 2012
  • Truncated ErbB2 expressed in tumor cell nuclei contributes to acquired therapeutic resistance to ErbB2 kinase inhibitors, Xia W, Liu Z, Zong R, Liu L, Zhao S, Bacus SS, Mao Y, He J, Wulfkuhle JD, Petricoin EF 3rd, Osada T, Yang XY, Hartman ZC, Clay TM, Blackwell KL, Lyerly HK, Spector NL, 2011
  • Differential methylation of CpG islands within the dermo1 gene promoter in several cancer cell lines, Mao Y, Toh HB, Ding Z, Sun L, Hong L, Chen CS, Wu X, 2011
  • D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms, Liu M, Li C, Pazgier M, Li C, Mao Y, Lv Y, Gu B, Wei G, Yuan W, Zhan C, Lu WY, Lu W, 2010
  • Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways, Ouyang G, Yao L, Ruan K, Song G, Mao Y, Bao S, 2009
  • Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt-mediated HIF-1alpha up-regulation and MMP9 activation, Song G, Ouyang G, Mao Y, Ming Y, Bao S, Hu T, 2009
  • Upregulated expression of periostin by hypoxia in non-small-cell lung cancer cells promotes cell survival via the Akt/PKB pathway, Ouyang G, Liu M, Ruan K, Song G, Mao Y, Bao S, 2009
  • Osteopontin prevents curcumin-induced apoptosis and promotes survival through Akt activation via alpha v beta 3 integrins in human gastric cancer cells, Song G, Ming Y, Mao Y, Bao S, Ouyang G, 2008
  • ATPase domain of Hsp70 exhibits intrinsic ATP-ADP exchange activity, Mao Y, Deng A, Qu N, Wu X, 2006
  • Hydrogen peroxide-induced apoptosis in human gastric carcinoma MGC803 cells, Mao Y, Song G, Cai Q, Liu M, Luo H, Shi M, Ouyang G, Bao S, 2006
  • Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells, Shi M, Cai Q, Yao L, Mao Y, Ming Y, Ouyang G, 2005
Tumor Pathology Cancer Diagnosis Molecular Mechanism Oncology Research Disease Biology

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.